SCM

Sio Capital Management Portfolio holdings

AUM $249M
This Quarter Return
-1.71%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$132M
AUM Growth
+$132M
Cap. Flow
-$87.3M
Cap. Flow %
-65.99%
Top 10 Hldgs %
71.81%
Holding
61
New
12
Increased
4
Reduced
14
Closed
18

Sector Composition

1 Healthcare 88.82%
2 Industrials 1.93%
3 Consumer Discretionary 0.92%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VKTX icon
26
Viking Therapeutics
VKTX
$3.04B
$699K 0.36% +554,382 New +$699K
SYRE icon
27
Spyre Therapeutics
SYRE
$996M
$690K 0.35% +141,874 New +$690K
OASM
28
DELISTED
Oasmia Pharmaceutical AB
OASM
$424K 0.22% 123,000
PFNX
29
DELISTED
Pfenex Inc.
PFNX
$411K 0.21% 49,092 -614,084 -93% -$5.14M
TEAR
30
DELISTED
TearLab Corporation
TEAR
$407K 0.21% +635,442 New +$407K
PETX
31
DELISTED
Aratana Therapeutics, Inc.
PETX
$378K 0.19% +59,869 New +$378K
IMNP
32
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$79K 0.04% 197,655
ALNY icon
33
Alnylam Pharmaceuticals
ALNY
$58.5B
-153,778 Closed -$9.65M
ECL icon
34
Ecolab
ECL
$78.6B
0
EDIT icon
35
Editas Medicine
EDIT
$231M
-7,714 Closed -$266K
JAZZ icon
36
Jazz Pharmaceuticals
JAZZ
$7.75B
0
JNJ icon
37
Johnson & Johnson
JNJ
$427B
0
LLY icon
38
Eli Lilly
LLY
$657B
-140,392 Closed -$10.1M
LNTH icon
39
Lantheus
LNTH
$3.73B
-446,098 Closed -$843K
NSPR icon
40
InspireMD
NSPR
$102M
-7,182 Closed -$4K
NVO icon
41
Novo Nordisk
NVO
$251B
0
NVS icon
42
Novartis
NVS
$245B
-94,988 Closed -$6.88M
PFE icon
43
Pfizer
PFE
$141B
0
SAGE
44
DELISTED
Sage Therapeutics
SAGE
0
SCYX icon
45
SCYNEXIS
SCYX
$34.9M
-284,556 Closed -$1.15M
SGMO icon
46
Sangamo Therapeutics
SGMO
$157M
-395,496 Closed -$2.39M
SRPT icon
47
Sarepta Therapeutics
SRPT
$1.78B
0
UTHR icon
48
United Therapeutics
UTHR
$13.8B
-77,317 Closed -$8.62M
RAD
49
DELISTED
Rite Aid Corporation
RAD
-412,784 Closed -$3.36M
AGRX
50
DELISTED
Agile Therapeutics, Inc
AGRX
-165,188 Closed -$1.03M